Menarini Group and MEDSIR Present the Phase III Study ADELA: A New Therapeutic Strategy for Advanced Breast Cancer
ADELA, an international phase III study being conducted across multiple countries, combines…
MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS)
MEDSIR, a leader in independent clinical research in oncology, strengthens its commitment…
